epithalon oral bioavailability percentage IV versus Approaches for Enhancing Oral Bioavailability

10.1002/ddr.21274 Drug Dev

Gut Health, Leaky Gut Repair, and Systemic Inflammation Control Because BPC-157 originates from a gastric peptide, it also has regenerative effects on: Stomach lining (ulcers, gastritis) Intestinal barrier (tight junction restoration) Gut-brain signaling (mood, sleep, focus) This makes it particularly useful for: Athletes using NSAIDs or oral PEDs Individuals with IBS, IBD, or celiac Users with chronic bloating, fatigue, or GI inflammation Oral BPC-157 demonstrated potent anti-ulcer properties and restored epithelial integrity in models of induced intestinal inflammation. Petrovic et al., Inflammopharmacology 6

Drugs@FDA: FDA-Approved Drugs database

The MHRA opened investigations in April 2026 into UK clinics doing exactly this kind of marketing